ABCC2 and ovarian cancer: However, in contrast with these data, other studies failed to show a significant association between MRP2 expression and chemosensitivity in patients with ovarian cancer (Arts et al, 1999; Materna et al, 2004) or lung cancer (Filipits et al, 2007; Kim et al, 2009).